Cancer Letters
Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience
Publication date: Available online 8 March 2023Source: Cancer LettersAuthor(s): Jaewang Lee, Jong-Lyel Roh
Cancer Letters
The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy
Publication date: Available online 8 March 2023Source: Cancer LettersAuthor(s): Brendan Moran, Maria Davern, John V. Reynolds, Noel E. Donlon, Joanne Lysaght
Cancer Letters
Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation
Publication date: Available online 8 March 2023Source: Cancer LettersAuthor(s): Sonia Coni, Rosa Bordone, Devon Michael Ivy, Zuleyha Nihan Yurtsever, Laura Di Magno, Rodrigo D’Amico, Bianca Cesaro, Alessandro Fatica, Francesca Belardinilli, Francesca B…
Cancer Letters
Good or bad: Paradox of plasminogen activator inhibitor 1 (PAI-1) in digestive system tumors
Publication date: Available online 6 March 2023Source: Cancer LettersAuthor(s): Bofang Wang, Baohong Gu, Tao Zhang, Xuemei Li, Na Wang, Chenhui Ma, Lin Xiang, Yunpeng Wang, Lei Gao, Yang Yu, Kewei Song, Puyi He, Yueyan Wang, Jingyu Zhu, Hao Chen
Cancer Letters
MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer
Publication date: Available online 5 March 2023Source: Cancer LettersAuthor(s): Yoshihiro Morimoto, Nami Yamashita, Haruka Hirose, Atsushi Fushimi, Naoki Haratake, Tatsuaki Daimon, Atrayee Bhattacharya, Rehan Ahmad, Yozo Suzuki, Hidekazu Takahashi, Don…
Cancer Letters
Enhanced E6AP-mediated ubiquitination of ENO1 via LINC00663 contributes to radiosensitivity of breast cancer by regulating mitochondrial homeostasis
Publication date: Available online 4 March 2023Source: Cancer LettersAuthor(s): Jianli Ma, Junwen Zhu, Jingtong Li, Ji Liu, Xiaofeng Kang, Jinming Yu
Cancer Letters
Editorial Board
Publication date: 1 April 2023Source: Cancer Letters, Volume 558Author(s):
Cancer Letters
Hepatoid adenocarcinoma—Clinicopathological features and molecular characteristics
Publication date: Available online 1 March 2023Source: Cancer LettersAuthor(s): Ming Li, Yan-Xia Mei, Ji-Hang Wen, Yu-Rong Jiao, Qiang-Rong Pan, Xiang-Xing Kong, Jun Li
Cancer Letters
Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance<sup>1</sup>
Publication date: Available online 28 February 2023Source: Cancer LettersAuthor(s): Jianfeng Peng, Xiaoyan Yin, Wenhua Yun, Xiangjiao Meng, Zhaoqin Huang
Cancer Letters
Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma
Publication date: Available online 24 February 2023Source: Cancer LettersAuthor(s): Boxin Zhang, Hao Li, Yuan-Tong Liu, Dian Xiong, Lu Zhang, Zhi-Jun Sun